Treatment for colorectal liver metastases: A review

Langenbeck's Archives of Surgery

Volumn 394, Issue 6, 2009, Pages 973-983

  Shimada, Hiroshi ^a   Tanaka, Kuniya ^b   Endou, Itaru ^b   Ichikawa, Yasushi ^b  

^a NATIONAL INSTITUTE OF OCCUPATIONAL SAFETY AND HEALTH   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Colorectal liver metastases treatment; Hepatectomy; Perioperative chemotherapy

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; GEFITINIB; IRINOTECAN; OXALIPLATIN; PANITUMUMAB;

CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; DRUG HALF LIFE; HUMAN; LIVER METASTASIS; LIVER RESECTION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR VOLUME;

ABLATION TECHNIQUES; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70350274290     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-009-0530-8     Document Type: Review

References (133)

1. T Rastogi A Hildesheim R Sinha 2004 Opportunities for cancer epidemiology in developing countries Nat Rev Cancer 4 909 917 1:CAS:528:DC%2BD2cXptFegtrc%3D 15516963
2. AM Bovier L Remontet E Jougla 2004 Incidence of gastrointestinal cancers in France Gastroenterol Clin Biol 28 877 881
3. J Faivre S Manfredi AM Bouvier 2003 Epidemiology of colorectal cancer liver metastases Bull Acad Natl Med 187 815 822 14979048
4. JS Wagner MA Adson JA Van Heerden MH Adson DM Ilstrup 1984 The natural history of hepatic metastases from colorectal cancer Ann Surg 199 502 508 1:STN:280:DyaL2c3gt1Sjuw%3D%3D 6721600
5. EK Abdalla JN Vanthey LM Ellis V Ellis R Pollock KR Bronglio K Hess SA Curley 2004 Recurrence and outcomes following hepatic resection, radiofrequency ablation and combined resection/ablation for colorectal liver metastases Ann Surg 239 818 825 15166961
6. P Rougier C Milan F Lazorthes 1995 Prospective study of prognostic factors in patients with unresected metastases from colorectal cancer Br J Surg 82 1397 1400 1:STN:280:DyaK28%2FpslygtQ%3D%3D 7489177
7. A de Gramont A FIger M Seymour M Homerin A Hmissi J Cassidy C Boni H Cortes-Funes A Cervantes G Freyer D Papamichael N Le Bail C Lovet D Hendler F de Braud C Wilson F Morvan A Bonetti 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938 2947 10944126
8. SR Alberts WL Horvath WC Sternfeld RM Goldberg MR Mahorey K Dakhil SR Rowland S Nair DJ Sargent JH Donohue 2005 Oxaliplatin, fluorouracil and leucovorin for patients with unresectable liver only metastases from colorectal cancer: a North Central Cancer Treatment Group Phase II Study J Clin Oncol 23 9243 9249 1:CAS:528:DC%2BD28Xnt1yntw%3D%3D 16230673
9. S Benoist K Pautrat E Mitry R Rougier C Penna B Nordinger 2005 Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases Br J Surg 92 1155 1160 1:STN:280:DC%2BD2MvkvVKksQ%3D%3D 16035135
10. GJ Poston R Adam S Curley J Figueras D Haller F Kunilinger G Mewtha B Nordinger Y Patt J Premrose M Roh P Rougier 2005 OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer J Clinic Oncol 23 7125 7134
11. O Cunningham Y Humblet S Siena, et al. 2004 Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 337 345 1:CAS:528:DC%2BD2cXlvFGitbk%3D 15269313
12. H Hurwitz L Fehrenbacha W Norotomy, et al. 2004 Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335 2342 1:CAS:528:DC%2BD2cXks1Gjt74%3D 15175435
13. B Nordinger M Giuguet JC Vaillant, et al. 1996 Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scorning system to improve case selection based on 1568 patients Cancer 77 1254 1262
14. MD Smith RW Parks 2008 Prognostic models for predicting death after hepatectomy in individual with hepatic metastases from colorectal cancer World J Surg 32 1108 1109 1:STN:280:DC%2BD1czitFOqtw%3D%3D 18343973
15. M Arru L Aldrighetti R Casodi S DiPoLo E Orsenigo M Stella 2008 Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer World J Surg 22 93 103
16. TJ Gayowski S Iwatsuki JR Madariaga R Selby S Todo W Iris TE Starzl 1994 Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathological risk factors Surgery 116 703 711 1:STN:280: DyaK2M%2Fis1Cmtg%3D%3D 7940169
17. K Tanaka H Shimada Y Fujii I Endo H Sekido S Togo H Ike 2004 Prehepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver Langenbeck Arch Surg 389 371 379
18. Y Kanemitsu T Kato 2008 Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer World J Surg 32 1097 1107 18200429
19. M Ree PP Tekkis FKS Welsch, et al. 2008 Evaluation of long term survival after hepatic resection for metastatic colorectal cancer. A multifactorial model of 929 patients Ann Surg 247 125 135
20. K Tanaka R Adam H Shimada, et al. 2003 Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver Br J Surg 90 963 969 1:STN:280:DC%2BD3szntVSltA%3D%3D 12905549 (Pubitemid 37026325)
21. S Zakaria JH Donohue FG Que, et al. 2007 Hepatic resection for colorectal metastases: value for risk scoring system? Ann Surg 246 183 191 17667495
22. Y Fong J Fortner RL Sun, et al. 1999 Clinical risk score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive case Ann Surg 230 309 318 1:STN:280:DyaK1MvitFahsw%3D%3D 10493478
23. RM Small N Lubegky E Shmueli A Figer D Aderka RK Nakache JM Lausner M Ben-Haims 2009 Response to chemotherapy predicts survival following resection of hepatio colorectal metastases in patients treated with neoadjuvant therapy J Surg Oncol 99 93 98 19065637
24. R Adam G Pascal D Cartaign D Azoley V Delvart B Bernard Paule F Levi H Bismuth 2004 Tumor progression while on chemotherapy: a contra indication to liver resection for multiple colorectal metastases? Ann Surg 240 6 1052 1064 15570210
25. D Blatzer Y Kishi DM Maru, et al. 2008 Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases J Clin Oncol 17 5299 10:1200/JCO
26. R Adam DA Whicherts RJ de Haas T Aloia F Levi B Paule C Guettier F Kunstinger V Delvart D Azouley D Castaing 2008 Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncology 26 1635 1641
27. MCB Tan DC Linehan WG Hawkins BA Siegel SM Strasberg 2009 Chemotherapy-induced normalization of PDG uptake by colorectal liver metastases does not normally indicate complete pathologic response J Gastrointest Surg 11 1112 1119
28. AJ Bilchik G Poston R Adam MA Choti 2008 Prognostic variables for resection of colorectal cancer hepatic metastases: an evolving paradigm J Clin Oncol 26 5320 5321 18936470
29. E Van Custem B Nordinger R Adam, et al. 2006 Towards a pan-European consumes on the treatment of patients with colorectal liver metastases Eur J Cancer 42 2212 2221
30. GJ Poston J Figueres F Giuliante G Nuzzo AF Sobrero J-F Gigot B Nordinger R Adam T Graenberger M Choti AJ Bilckit JD Van Custem JM Chiang M D'Angelica 2008 Urgent need for a new staging system in advanced colorectal cancer J Clin Oncol 26 4828 4833 18711170
31. C Tournigand T Andre E Acille, et al. 2004 FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GEROR study J Clin Oncol 22 229 237 1:CAS:528:DC%2BD2cXpsVKit7w%3D 14657227
32. L Cals O Rixe E Francois, et al. 2004 Dose-finding study of weekly 24 h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patients Ann Oncol 15 1018 1024 1:STN:280:DC%2BD2czgt1Sqtw%3D%3D 15205194
33. D Cunningham Y Humblet S Siena, et al. 2004 Cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Eng J Med 351 337 345 1:CAS:528:DC%2BD2cXlvFGitbk%3D
34. LB Saltz JV Cox C Blanke, et al. 2000 Irinotecan plus fluorouracil and leucovorin for metastatic colorectal center, Irinotecan Study Group N Eng J Med 343 905 914 1:CAS:528:DC%2BD3cXntFOkt7Y%3D
35. J Tabernero E Van Custem E Diaz-Rubio, et al. 2007 Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first line treatment of metastatic colorectal cancer J Clin Oncol 25 5225 5232 1:CAS:528:DC%2BD2sXhsVKnsbzI 18024868
36. LB Saitz NJ Meropol PJ Loehrer Sr, et al. 2004 Phase II trial of cetuximab in patients with refractomy colorectal cancer that express the epidermal growth factor receptor J Clin Oncol 22 1201 1208
37. H Bismuth R Adam F Levi C Farabos F Waechter D Castaing P Majno L Engerran 1996 Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy Ann Surg 224 509 522 1:STN:280: DyaK2s%2FhtVyhsA%3D%3D 8857855
38. R Adam V Delvart G Pascal A Valeanu D Castaing D Azoulay S Giacchetti B Paul F Kumstlinger O Ghemard F Levi H Bismuth 2004 Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 644 657 15383792
39. R Adam E Avisar A Ariche S Giachetti D Azoulay D Castaing F Kunstlinger F Levi F Bismuth 2001 Five-year survival following hepatic resection after neoadjuvant therapy for non-resectable colorectal cancer Ann Surg Oncol 8 347 353 1:STN:280:DC%2BD3M3lsVWntg%3D%3D 11352309
40. G Folprecht MP Lutz P Schoffski, et al. 2006 Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma Ann Oncol 17 450 456 1:STN:280: DC%2BD287ht1Olug%3D%3D 16303861
41. A Abad B Massuti A Anton, et al. 2007 Colorectal cancer metastases resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluouracil: final results of a phase II study Acta Oncol 47 286 292
42. C Barone G Nuzzo A Casseno, et al. 2007 Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases Br J Cancer 97 1035 1039 1:CAS:528:DC%2BD2sXhtFKktb%2FL 17895897
43. Kemeny NE, Huitzil Melendez FD, Capanu M, et al (2009) Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol (in press). doi: 10.1200/JCO.2008.20.1301
44. L Zelck R Bugat D Cherqui, et al. 2003 Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in nonresectable hepatic metastases from colorectal cancer Ann Oncol 14 1537 1542
45. R Adam T Aloia F Levin DA Wicherts RJ de Hans B Paule, et al. 2007 Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy J Clin Oncol 25 4593 4602 1:CAS:528:DC%2BD2sXht1yhsr%2FL 17925554
46. G Folprecht A Grothey S Alberts, et al. 2005 Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumor response and resection rate Ann Oncol 16 1311 1319 1:STN:280:DC%2BD2MzotFamsA%3D%3D 15870084
47. L Capussotti A Muratore MM Mulas P Massucco M Agliatta 2006 Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases Br J Surg 93 1001 1006 1:STN:280:DC%2BD28rgsVSktw%3D%3D 16739103 (Pubitemid 44214852)
48. G Nuzzo F Giuliante F Ardito M Vellone C Pozzo A Cassano I Giovanni C Barone 2007 Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy J Gastrointest Surg 11 318 324 17458605
49. M Ducreux M Ychou A Laplanche, et al. 2005 Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the federation national des centre de butte contre le cancer J Clin Oncol 23 4881 4887 1:CAS:528:DC%2BD2MXpsFWmt7k%3D 16009952
50. S Mocellin P Piloti M Lise D NiHi 2007 Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol 25 5649 5654 18065736
51. D Kerr C McAdrede J Ledermann, et al. 2003 Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomized trial Lancet 61 368 373
52. A Cohen N Kemeny 2003 An update on hepatic arterial infusion chemotherapy for colorectal cancer Oncologist 8 553 566 14657534
53. B Nordlinger R Parc E Delva, et al. 1987 Hepatic resection for colorectal liver metastases Ann Surg 205 256 263 1:STN:280:DyaL2s7lsFGgsA%3D%3D 3827361
54. R Parks M Gonen N Kemeny W Jarnagin, et al. 2007 Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents J Am Coll Surg 204 753 763 17481478
55. R Adam G Pascal D Cartaizn D Azoley V Delvart B Bernard Paule F Levi H Bismuth 2004 Tumor progression while on chemotherapy: a contra indication to liver resection for multiple colorectal metastases? Ann Surg 240 6 1052 1064 15570210
56. K Tanaka R Adam H Shimada D Azoulay F Levi H Bismuth 2003 Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver Br J Surg 90 963 969 1:STN:280:DC%2BD3szntVSltA%3D%3D 12905549 (Pubitemid 37026325)
57. S Benoist A Brouquet C Penna, et al. 2006 Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24 3939 3945 16921046
58. J LeCouter DR Moritz B Li, et al. 2003 Angiogenesis-independent endothelial protection of liver: role of VEGFR1 Science 299 890 893 1:CAS:528:DC%2BD3sXpt1Shuw%3D%3D 12574630
59. MS Gordon K Margolin M Talpaz, et al. 2001 Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer J Clin Oncol 19 843 850 1:CAS:528:DC%2BD3MXhtlGrt7k%3D 11157038
60. P Tyagi A Grothey 2006 Commentary on a phase III trial of bevacizumab plus XELOX or FOLFOX4 for first-line treatment of metastatic colorectal cancer: the NO16966 trial Clin Colorectal Cancer 6 261 264 1:CAS:528: DC%2BD2sXhsVSmtrw%3D 17241510
61. B Gruenberger D Tamandle J Schuller W Scheithauer C Zielinsk F Hebstand T Grenberger 2008 Bevacizumab, Capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer J Clin Oncol 26 11 1830 1835 1:CAS:528:DC%2BD1cXmsFemsbg%3D 18398148
62. KS Reddy AM Horse IH Hurwitz CJ Bendel JT Gan ET Hill MB Clary 2008 Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases J Am Coll Surg 206 96 106 18155574
63. E Van Custem I Lang G D'Laens, et al. 2008 KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer treated with FOLFILI or without cetuximab: the CRYSTAL experience J Clin Oncol 26 Suppl 5s Abstr 2
64. C Bokemeyer I Bandarenko A Mahkson Jt Jartmann 2009 Fluorouracil leucovorin and oxaliplatin with or without cetuximab in the first-line treatment of metastatic colorectal cancer J Clin Oncol 27 663 671 1:CAS:528: DC%2BD1MXjsVCjsrk%3D 19114683
65. M Fakih 2008 Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach? Expert Rev Anticancer Ther 8 1471 1480 1:CAS:528:DC%2BD1cXhtVOhsrrM 18759698
66. B Nordlinger 2008 Preoperative chemotherapy with FOLFOX4 and surgery versus surgery alone for respectable liver metastases from colorectal cancer (EORTC 40983): a randomised controlled trial Lancet 371 1007 1016 1:CAS:528:DC%2BD1cXjs1Sltbg%3D 18358928
67. TM Pawlik K Olino AL Gleisner M Torbenson, et al. 2007 Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome J Gastrointest Surg 11 860 868 17492335
68. L Rubbia-Brandt V Audard SP Roth BC AD, et al. 2004 Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann Oncol 15 460 466 1:STN:280:DC%2BD2c7gvVeksQ%3D%3D 14998849
69. FG Fernandez J Ritter JW Goodwin DC Linehan, et al. 2005 Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases J Am Coll Surg 200 845 853 15922194
70. H Nakano E Oussultzoglou E Rosso S Casnedi, et al. 2008 Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal metastases receiving preoperative chemotherapy Ann Surg 247 118 124 18156931
71. D Zorzi A Laurent TM Pawlik GY Laumes JN Vauthey EK Abdalla 2007 Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases Br J Surg 97 274 286
72. K Washington KL Lane WC Mayers 1993 Nodular regenerative hyperplasia in partial hepatectomy specimens Am J Surg Pathol 17 1151 1158 1:STN:280: DyaK2c%2FislGmtA%3D%3D 8214260
73. JN Vauthey TM Pawlik D Ribero TT Wu PM Hoff, et al. 2006 Chemotherapy regimen predicts steatohepatitis and an increase in 90 days mortality after resection of hepatic colorectal metastases J Clin Oncol 24 2065 2072 1:CAS:528:DC%2BD28Xlt1amurY%3D 16648507
74. T Aloia M Sebagh M Plasse, et al. 2006 Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases J Clin Oncol 24 4983 4990 1:CAS:528:DC%2BD28Xht1GnurzI 17075116
75. K Tanaka H Shimada M Ueda K Matsuo I Endo, et al. 2008 Role of hepatectomy in treating multiple bilobar colorectal cancer metastases Surgery 143 259 270 18242343
76. KS Hughes RB Rosenstain S Songhorabodi, et al. 1988 Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors Dos Colon Rectum 31 1 4 1:STN:280:DyaL1c3htFemtg%3D%3D
77. J Sheele R Stangle A Altendorf-Hofmann FP Gall 1991 Indicators of prognosis after hepatic resection for colorectal secondaries Surgery 110 13 29
78. J Sheele R Stangle A Altendorf-Hofmann M Paul 1995 Resection of colorectal metastases World J Surg 19 59 71
79. MA Choti JV Sitzmann MF Tiburi W Sumetchotimetha, et al. 2002 Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 759 766 12035031
80. EK Abdalla JN Vauthey LM Ellis, et al. 2004 Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg 239 818 825 15166961
81. FG Fernandez JA Dnebin DC Linehan, et al. 2004 Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 FDG Ann Surg 240 438 447 15319715
82. TM Pawlik CR Scogins D Zorzi EK Abdalla, et al. 2005 Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases Ann Surg 241 715 722 15849507
83. M Lorenz HH Muller H Sharmann, et al. 1998 Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluouracil and folinic acid for liver metastases of colorectal cancer German Cooperative on Liver Metastases Ann Surg 228 756 762 1:STN:280:DyaK1M%2FnsFyitQ%3D%3D 9860474
84. JN Vauthey TM Pawlik EK Abdalla JF Arens RA Nemr, et al. 2004 Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 239 722 730 15082977
85. M Shoup MD Gonen M Angelica, et al. 2003 Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection J Gastrointest Surg 7 325 330 12654556
86. H Akita Y Sasaki T Yamada K Gotoh H Ohigashi, et al. 2008 Real-time intraoperative assessment of residual liver functional reserve using pulse Dye Densitometry World J Surg 32 2668 2674 18841411
87. EK Abdalla ME Hicks JN Vauthey 2001 Portal vein embolization: rationale, technique and future prospects Br J Surg 88 165 175 1:STN:280: DC%2BD3M7kt1Wjsg%3D%3D 11167863
88. K Tanaka H Shimada M Matsuo I Ueda I Endo S Togo 2007 Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases EJSO 33 329 335 1:STN:280:DC%2BD2s7pvFSjtQ%3D%3D 17140759
89. J Zacherl C Scheuba M Imhof M Zacherl, et al. 2002 Current value of intraoperative sonography during surgery for hepatic neoplasms World J Surg 26 550 554 12098044
90. K Yasui Y Shimizu 2005 Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes Int J Clin Oncol 10 86 96 15864693
91. N Kokudo Y Miki S Sugai A Yanagisawa Y Kato, et al. 2002 Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection Arch Surg 137 833 840 12093342
92. RJB Finch HZ Malik ZZR Hamady A Al-Mukhatar, et al. 2007 Effect of type of resection on outcome of hepatic resection for colorectal metastases Br J Surg 94 1242 1248 1:STN:280:DC%2BD2srms12gtw%3D%3D 17657718
93. D Zorzi JT Mullen EK Abdalla TM Pawlik A Andre, et al. 2006 Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases J Gastrointest Surg 10 86 94 16368496
94. B Cady RL Jenkis GD Steele WD Lewis HD Stone, et al. 1998 Surgical margin in hepatic resection for colorectal metastases: a critical and improvable determinant of outcome Ann Surg 227 566 571 1:STN:280:DyaK1c3itlSisw%3D%3D 9563547
95. C Are M Gonen K Zazzali, et al. 2007 The impact of margins on outcome after hepatic resection for colorectal metastasis Ann Surg 246 295 300 17667509
96. G Nuzzo F Giuliante F Ardio M Vellone I Giovanni B Fiderico FM Vecchio 2008 Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: single-center experience Surgery 143 384 393 18291260
97. A Altendorf-Hofmann J Sheele 2003 A critical review of the major indicator of prognosis after resection of hepatic metastases from colorectal carcinoma Surg Oncol Clin N Am 12 165 192 12735137
98. JC Weber H Nakano P Bachellier, et al. 2001 Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? Am J Surg 182 81 88 1:STN:280: DC%2BD3MvovFOmtg%3D%3D 11532423
99. S Jonas A Thelen C Benckert A Spinell, et al. 2007 Extended resections of liver metastases from colorectal cancer World J Surg 31 511 521 1:STN:280:DC%2BD2s7jsVyksg%3D%3D 17308854 (Pubitemid 46356071)
100. K Yasui T Hirai T Kato A Torii, et al. 1997 A new macroscopic classification predicts prognosis for patients with liver metastases from colorectal cancer Ann Surg 226 582 586 1:STN:280:DyaK1c%2FkvFamuw%3D%3D 9389391
101. D Jaeck H Nakano P Bachellier K Inoue, et al. 2002 Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study Ann Surg Oncol 9 430 438 12052752
102. R Adam A Laurent D Azouley D Castaing H Bismuth 2000 Two stage hepatectomy: a planned strategy to treat irresectable liver tumors Ann Surg 232 777 785 1:STN:280:DC%2BD3M%2FltVynuw%3D%3D 11088072
103. D Jaeck E Oussoutzoglou E Rosso, et al. 2004 A two-stage hepatectomy procedure combined with PVE to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases Ann Surg 240 1037 1051 15570209
104. AW Dennis R Miller RJ de Haas, et al. 2008 Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases Ann Surg 248 994 1005
105. V Pamecha B Nedjat-Shokouchi K Burusamy, et al. 2008 Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolization and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases Dig Surg 25 387 393 1:CAS:528:DC%2BD1cXhsFejtr3P 19033722
106. TM Pawlik F Izzo DS Cohen, et al. 2003 Combined resection and radio frequency ablation for advanced hepatic malignancies: results in 172 patients Ann Surg Oncol 10 1059 1069 14597445
107. AM El-gendi SE Khorsandi M Pai, et al. 2008 Repeat hepatic resection using a Rf-assisted technique Dig Surg 25 293 299 18769067
108. SA Curley 2003 Radiofrequency ablation of malignant liver tumors Ann Surg Oncol 10 338 347 12734080
109. AE Siperstein E Barber N Ballem T Parikh 2007 Survival after radiofrequency ablation of colorectal liver metastases-10 year experience Ann Surg 246 559 567 17893492
110. AJ Bilchik TF Wood DP Allegra 2001 Radiofrequency ablation of unresectable hepatic malignancies: lesson learned Oncologist 6 24 33 1:STN:280:DC%2BD3M7otVyrsA%3D%3D 11161226
111. E Berber M Tsinberg G Tellioglu, et al. 2008 Resection versus laparoscopic radio frequency thermal ablation of solitary colorectal liver metastasis J Gastrointest Surg 12 1967 1972 18688683
112. R Martin P Paty Y Fong, et al. 2003 Simultaneous live and colorectal resections are safe for synchronous colorectal liver metastases J Am Coll Surg 197 233 241 12892803
113. K Tanaka H Shimada K Matsuo Y Nagano I Endo H Sekido 2004 Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases Surgery 136 650 659 15349115 (Pubitemid 39186580)
114. L Capussotti A Ferrero L Vigano, et al. 2007 Major liver resection synchronous with colorectal surgery Ann Surg Oncol 14 195 201 17080238
115. JC Weber P Bachellier E Oussoultzoglow D Jaeck 2003 Simultaneous resection of colorectal primary tumor and synchronous liver metastases Br J Surg 90 956 1:STN:280:DC%2BD3szntVSltw%3D%3D 12905548
116. Y Fong AM Cohen JG Fortner, et al. 1997 Liver resection for colorectal metastases J Clin Oncol 15 938 946 1:STN:280:DyaK2s3htlynsA%3D%3D 9060531
117. D Elias JF Ouellet N Bellon, et al. 2003 Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases Br J Surg 90 567 574 1:STN:280:DC%2BD3s3htlSmuw%3D%3D 12734864
118. D Jaeck E Oussoultzoglou E Rosso 2007 Hepatectomy for colorectal metastases in the presence of extrahepatic disease Surg Oncol Clin N Am 16 507 523 17606191
119. M Inoue M Ohta K Iuchi, et al. 2004 Benefits of surgery for patients with pulmonary metastases from colorectal cancer Ann Thorac Surg 78 238 244 15223436
120. G Miller P Biernacki NE Kemeny, et al. 2007 Outcomes after resection of synchronous or metachronous hepatic and pulmonary metastases J Am Coll Surg 205 231 238 17660069
121. R Adam H Bismuth D Castaing, et al. 1997 Repeat hepatectomy for colorectal liver metastases Ann Surg 225 51 60 1:STN:280:DyaK2s7lt1Wrug%3D%3D 8998120
122. A Antonion RE Lovegrove HS Tilney, et al. 2007 Meta analysis of clinical outcome after first and second liver resection for colorectal metastases Surgery 141 9 18
123. M Minagawa M Makuuchi G Torzilli, et al. 2000 Extension of the frontiers of surgical indication in the treatment of liver metastases from colorectal cancer: long-term results Ann Surg 231 487 499 1:STN:280:DC%2BD3c3htlaisA%3D%3D 10749608
124. JY Douillard D Cumingham AD Roth, et al. 2000 Irinotecan combined with fluororacil compared with fluorouracil alone as first-live treatment for metastatic colorectal cancer: a multicenter randomized trial Lancet 355 1041 1047 1:CAS:528:DC%2BD3cXisFOnsb4%3D 10744089
125. RM Goldberg DJ Sargent RS Morant, et al. 2004 A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 23 30 1:CAS:528:DC%2BD2cXpsVKitbY%3D 14665611
126. M Ychou F Viret A Kramar F Desseigne E Mitry, et al. 2008 A tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFILINOX): a phase II study in colorectal cancer patients with nonresectable liver metastases Cancer Chemother Pharmacol 62 195 201 1:CAS:528:DC%2BD1cXlvVWitbc%3D 17901955
127. Quenet F, Nordinger B, Rivoire M (2004) Resection of previously unresectable liver metastases from colorectal cancer after chemotherapy CPT11/L-OHP/LV5FU (Fol firinox): a prospective II trial. Proc Am Soc Clin Oncol Abstr3613
128. H Hurwitz L Fehrevbacher W Novotny, et al. 2004 Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335 2342 1:CAS:528:DC%2BD2cXks1Gjt74%3D 15175435
129. A Falcone S Ricci I Brunetti, et al. 2007 Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIR) as first-line treatment for metastatic colorectal cancer J Clin Oncol 25 1670 1676 1:CAS:528:DC%2BD2sXlvFyktb8%3D 17470860
130. Y Okano J Yamamoto T Kosuge S Ymamamoto M Sakamoto Y Nakanishi S Hirohashi 2000 Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma. Clinicopathological study of 152 first resection cases Cancer 89 267 275 1:STN:280:DC%2BD3czpt12qug%3D%3D 10918155
131. A Grothey D Sargent RM Goldberg, et al. 2004 Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment J Clin Oncol 22 1209 1214 1:CAS:528:DC%2BD2cXpsVGktLo%3D 15051767
132. C Pozzo M Basso A Cassano, et al. 2004 Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients Ann Oncol 15 933 939 1:STN:280: DC%2BD2c3lt12jsQ%3D%3D 15151951
133. Van Custem E, Nowacki M, Long I et al (2007) Randomized phase III study of irinotecan and 5FU/FA with or without cetuximab in the first-live treatment of patients with metastatic colorectal cancer the crystal trial. ASCO Annual Meeting, 2007; abst